AASTOCKS Financial News

HSI¹	24,180.71	+108.43	158.72B
HSCEI¹	8,712.17	+33.87	52.21B

Back Zoom + Zoom - Block Traded

Nomura Lifts INNOVENT BIO (01801.HK) TP to HKD89.8, Maintains Buy Rating
2025-06-30 10:45:27
Nomura published a research report, covering INNOVENT BIO (01801.HK), which held an oncology R&D day in Shanghai last Saturday (28th), where the company's significant project IBI363 (PD-1/IL2) received focused attention.

Nomura increased the risk-adjusted peak sales forecast for IBI363 to RMB5.9 billion and raised the target price from HKD54.6 to HKD89.8, maintaining a Buy rating.
~

AASTOCKS Financial News
Website: www.aastocks.com

(1) HK Indices are real time

Home|RT Quote|Market|News|Indices
Feedback

View: Mobile|Desktop
Lang: 繁|简|EN

Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.